Press "Enter" to skip to content

Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition

0
Listen to this article

Here’s a copy of the recent talk on Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition. It’s based on the book Make Better Decisions, which distills insights gained from more than two decades of providing guidance to biopharmaceutical companies.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry
✓ 505(b)(2) & Biosimilars
✓ Insightful Articles & Case Studies
✓ Patent Litigation & Challenges

First 30 days free

➤ Sign up
Do NOT follow this link or you will be banned from the site!